Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 30;5(2):112-119.
doi: 10.1515/jtim-2017-0017. eCollection 2017 Jun.

Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic

Des Crowley  1 , Walter Cullen  2 , Eamon Laird  3 , John S Lambert  4 , Tina Mc Hugh  5 , Carol Murphy  4 , Marie Claire Van Hout  6
Affiliations

Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic

Des Crowley et al. J Transl Int Med. .

Abstract

Background and objectives: Hepatitis C virus (HCV) infection is a major public health issue. There is substandard uptake in HCV assessment and treatment among people who inject drugs (PWID). Community fibroscanning is used to assess disease severity and target treatment.

Methods: A survey was administered to a cohort of chronically HCV infected patients attending a community fibroscanning clinic. Questions targeted diagnosis of HCV, suitability, willingness and barriers to engagement in treatment. Descriptive and regression analysis, with thematic analysis of open-ended data was conducted.

Results: There was high acceptance of community fibroscanning among this cohort with over 90% (68) attending. High levels of unemployment (90%) and homelessness (40%) were identified. Most patients were on methadone treatment and had been HCV infected for greater than 10 years with length of time since HCV diagnosis being significantly longer in patients with fibroscan scores > 8.5 kPa (P = 0.016). With each unit increase in methadone dose, the odds of the >8.5 fibroscan group increased by 5.2%. Patient identified barriers to engagement were alcohol and drug use, fear of HCV treatment and liver biopsy, imprisonment, distance to hospital and early morning appointments.

Conclusion: The study highlights the usefulness of community fibroscanning. Identifying barriers to treatment in this cohort affords an opportunity to increase the treatment uptake. The availability of afternoon clinics and enhanced prison linkage are warranted.

Keywords: blood borne virus; drug users; fibroscan; hepatitis C virus; opiate substitution treatments.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest All authors declare no conflict of interest.

References

    1. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D. et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571–83. - PMC - PubMed
    1. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013;57:S32–8. - PMC - PubMed
    1. Scheidell JD, Khan MR, Clifford LM, Dunne EM, Keen LD, Latimer WW. Gender differences in planning ability and hepatitis C virus among people who inject drugs. Addict Behav. 2015;47:33–7. - PMC - PubMed
    1. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL. et al. Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend. 2007;89:1–12. - PMC - PubMed
    1. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002;36:S99–105. - PubMed

LinkOut - more resources